Efficacy and safety of triplet chemotherapy plus anti-EGFR agents in metastatic colorectal cancer: a systematic review and meta-analysis

BACKGROUND: To date, the optimal treatment for potentially resectable metastatic colorectal cancer (mCRC) patients has yet to be determined. Encouraging results have been reported in studies exploring the efficacy of triplet chemotherapy plus anti-epidermal growth factor receptor (anti-EGFR) target...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qian, Wang, Huan, Zhang, Suqin, Zeng, Yifei, Yang, Wei, Pan, Wenjun, Hong, Guodai, Gao, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377107/
https://www.ncbi.nlm.nih.gov/pubmed/35965307
http://dx.doi.org/10.1186/s12957-022-02707-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377107/
https://www.ncbi.nlm.nih.gov/pubmed/35965307
http://dx.doi.org/10.1186/s12957-022-02707-x

Ejemplares similares